MusclePharm Logo to be Prominently Featured During Strikeforce Event: Diaz vs. Daley on Showtime
DENVER, April 8, 2011 /PRNewswire/ -- MusclePharm Corporation, a Nevada corporation ("MusclePharm" or the "Company") (OTCBB: MSLP), an expanding U.S. healthy lifestyle company, is pleased to announce that it will be prominently featured during Saturday's Strikeforce: Diaz vs. Daley fight card, which takes place at Valley View Casino Center in San Diego, California and will be broadcast live on Showtime cable network.
MusclePharm will have significant mat placement in the cage for the event, which will be available live to Showtime's 16.5 million subscribers.
This will be Strikeforce's first major event since it was purchased by Zuffa, LLC ("Zuffa"), which is the parent company of the Ultimate Fighting Championship (UFC). Zuffa acquired Strikeforce on March 12. In the main event, Nick Diaz defends his welterweight title against challenger Paul "Semtex" Daley.
Thanks to his entertaining style and brash personality, Diaz has been involved in several of Strikeforce's most viewed telecasts on Showtime, which we believe will allow for greater exposure for MusclePharm during the broadcast.
The co-main event features current lightweight champion Gilbert "El Nino" Melendez fighting Tatsuya "Crusher" Kawajiri.
About MusclePharm Corporation
Headquartered in Denver, Colorado, MusclePharm is a healthy life-style company that develops and manufactures a full line of National Science Foundation approved nutritional supplements that are 100% free of banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts, and Major League Baseball. The Company's products address all categories of an active lifestyle, including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets, including GNC and Vitamin Shoppe. MusclePharm products are also sold in over 100 online stores, including bodybuilding.com, Amazon.com and Vitacost.com. For more information, please visit www.musclepharm.com.
Forward Looking Statements
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
SOURCE MusclePharm Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article